- E Wave Deceleration Rate [CMO:0002505] — Measurement of the decrease in transmitral blood flow velocity per unit time or the rate at which the velocity of passive blood flow from the atrium to the ventricle decreases over time as the ventricle fills and the atrium empties, calculated as the slope of transmitral velocity vs time.
- E Wave Deceleration Time [CMO:0002504] — An echocardiographic measurement of the amount of time between the maximum 'E point', that is, the maximum velocity of passive blood flow from the atrium to the ventricle, and the return to baseline at the end of early mitral flow.
- E Wave Velocity [CMO:0002503] — Measurement of the speed at which blood flows into the ventricle during passive filling, that is, during the period when the blood flows from the atrium to the ventricle due to gravity rather than as a result of active contraction of the atrium.
- E' Wave Velocity [CMO:0002873] —
- E/A Wave Ratio [CMO:0002789] — A calculated measurement in which the value of the E wave (that is, the velocity of the blood flow across the mitral valve during passive filling of the left ventricle in early diastole) is divided by the value of the A wave (that is, the velocity of the blood flow across the mitral valve during active filling of the left ventricle caused by atrial contraction in late diastole).
- E/E' Wave Ratio [CMO:0002862] —
- Ear Measurement [CMO:0002667] —
- Ear Ribonucleic Acid Level [CMO:0003975] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in the ear, the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance.
- Effective Renal Plasma Flow [CMO:0001916] — A calculated measurement of the amount of plasma that perfuses the renal tubules per unit time, derived by measurement of the clearance rate of a non-metabolizable solute such as para-aminohippurate (PAH). The effective RPF is approximately 10% less than the actual RPF. Plasma is the fibrinogen-containing fluid portion of the blood in which the particulate components are suspended. The kidneys are the paired organs that function to maintain proper water and electrolyte balance, regulate acid-base concentration, and filter the blood of metabolic wastes.
- Efferent Arteriolar Hydraulic Pressure [CMO:0002985] — Force exerted on the luminal vessel wall from fluid flowing through the efferent arteriole.
- Efferent Arteriolar Plasma Flow Rate [CMO:0003697] — Volume of blood plasma delivered by a single glomerulus per unit time.
- Efferent Arteriolar Plasma Protein Concentration [CMO:0002976] —
- Efferent Arteriolar Resistance [CMO:0002972] — Resistance to blood flow measured within the efferent arteriole proximal to a glomerular capillary network.
- Efferent Colloid Osmotic Pressure [CMO:0002978] — A form of osmotic pressure exerted by proteins, notably albumin, in the efferent arteriole's plasma that tends to pull water into the circulatory system. It is the opposing force to hydrostatic pressure. It has a major effect on the pressure across the glomerular filter
- Egg Albumen Height, Fowl [CMO:0001343] — The height of the inner thick albumen (egg white) when a bird's egg is broken onto a flat surface.
- Egg Albumen Measurement, Fowl [CMO:0001336] — Any measurement of the nutritive and protective gelatinous substance (egg white) surrounding the yolk of a bird's egg.
- Egg Albumen Percentage, Fowl [CMO:0001344] — The weight of the nutritive and protective gelatinous substance (egg white) surrounding the yolk of a bird's egg, expressed as a percentage of total egg weight.
- Egg Albumen Weight, Fowl [CMO:0001342] — The relative heaviness of the nutritive and protective gelatinous substance (egg white) surrounding the yolk of a bird's egg.
- Egg Length, Fowl [CMO:0001345] — The length from end to end, that is, the linear extent along the longest axis, of a bird's egg, the ovum in combination with its nutrient stores and protective outer coverings.
- Egg Measurement, Fowl [CMO:0000402] — Any measurement of all or part of an ovum in combination with its nutrient stores and protective outer coverings, of a bird.
- Egg Number, Fowl [CMO:0000397] —
- Egg Production Rate, Fowl [CMO:0000396] — Number of eggs laid by a bird divided by the number of days over which the eggs are produced.
- Egg Specific Gravity, Fowl [CMO:0001347] — The ratio of the mass of a bird's egg to the mass of an equal volume of water at a specified temperature.
- Egg Weight, Fowl [CMO:0001333] — The relative heaviness of an ovum in combination with its nutrient stores and protective outer coverings, of a bird.
- Egg Width, Fowl [CMO:0001346] — The diameter across the short axis of a bird's egg, the ovum in combination with its protective outer coverings.
- Egg Yolk Height to Diameter Ratio, Fowl [CMO:0000403] — The height of the egg yolk of a bird divided by the diameter of the yolk.
- Egg Yolk Measurement, Fowl [CMO:0001334] — Any measurement of the portion of the egg of a bird that consists of protein and fat from which the early embryo gets its main nourishment.
- Egg Yolk Weight, Fowl [CMO:0000395] — Weight of the yellow portion of the egg of a bird.
- Eggshell Color, Fowl [CMO:0001339] — The visually perceived hue of the outermost protective covering of a bird's egg.
- Eggshell Measurement, Fowl [CMO:0001335] — Any measurement of the outermost protective covering of a bird's egg.
- Eggshell Percentage, Fowl [CMO:0001338] — The weight of the rinsed and dried eggshell, expressed as a percentage of total egg weight.
- Eggshell Strength, Fowl [CMO:0001340] — The force required to fracture the hard outermost covering of a bird's egg.
- Eggshell Thickness, Fowl [CMO:0001341] — The thickness, that is, the length or extent of the dimension between the inner and outer surfaces of an eggshell, the outermost protective covering of a bird's egg.
- Eggshell Weight, Fowl [CMO:0001337] — The relative heaviness of the rinsed and dried outermost protective covering of a bird's egg.
- Ejaculation Duration [CMO:0000399] — The length of time required from start to finish for the expulsion of semen from the male urethra.
- Ejaculation Measurement [CMO:0000398] —
- Ejection Fraction [CMO:0000180] — Percentage of blood pumped out of the left ventricle with each heart beat.
- Elbow Breadth [CMO:0000293] — In humans this measurement is commonly performed with the individual's arm extended perpendicular to the body and bent with the fingers pointing up so the angle at the elbow is 90 degrees. The greatest distance across the elbow joint is used for the measurement.
- Electrical Activity Measurement of Retina [CMO:0003653] — A measurement of electrical signal (amplitude/voltage) generated in the retina after stimulation by flashing or flickering of light.
- Elimination Half-life of Nifedipine in the Plasma [CMO:0003133] — The time it takes for the body to eliminate or breakdown half of a dose of this potent vasodilator agent, in practice the time taken for plasma concentration of nifedipine to be reduced by 50%.
- Embryonic Cell/tissue Ribonucleic Acid Level [CMO:0003986] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in embryonic cells or tissue.
- Encephalitis Incidence/prevalence Measurement [CMO:0002361] — Any measurement in which the number of individuals in a study population that display encephalitis at a point in time or develop encephalitis within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Encephalitis is inflammation of the brain due to infection, autoimmune processes, toxins, and other conditions.
- Encephalitis Onset/diagnosis Measurement [CMO:0002371] — Any measurement which expresses a quantity related to the beginning, early stages or development of encephalitis, an inflammation of the brain, or to the official determination of encephalitis as the cause of the observed symptom(s).
- End-diastolic Volume [CMO:0000221] — Volume of blood in left ventricle immediately before a contraction.
- End-systolic Volume [CMO:0000181] — Volume of blood in left ventricle at end of contraction.
- End-tidal Partial Pressure of Carbon Dioxide (PETCO2) [CMO:0000133] — The amount of carbon dioxide present in air exhaled from the lungs.
- Endocrine Gland Measurement [CMO:0001053] — Any measurement of an endocrine gland, that is, a ductless gland that produces and secretes hormones directly into the blood or lymph.
- Endocrine/exocrine System Measurement [CMO:0000783] — Measurements involving organs or structures which release their products into the blood or lymph (endocrine) or through a duct opening on an internal or external surface of the body (exocrine).
- Endometrial Adenocarcinoma Incidence/prevalence Measurement [CMO:0001789] — Any measurement in which the number of individuals in a study population that display endometrial adenocarcinomas at a point in time or develop endometrial adenocarcinomas within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. An endometrial adenocarcinoma is an abnormal and malignant growth of the epithelial cells of the mucous membrane lining the uterus that results from uncontrolled, progressive multiplication of cells, serves no physiological function, and forms or appears to form glandular structures.
- Endometrial Adenocarcinoma Measurement [CMO:0001788] — Any measurement of an abnormal and malignant growth of the epithelial cells of the mucous membrane lining the uterus that results from uncontrolled, progressive multiplication of cells, serves no physiological function, and forms or appears to form glandular structures.
- Endometrial Cancer Ribonucleic Acid Level [CMO:0004004] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in a malignant tumor of the endometrium, the glandular mucous membrane lining of the uterine cavity that is hormonally responsive during the estrous/menstrual cycle and during pregnancy.
- Endometrial Tumor Measurement [CMO:0001787] — Any measurement of an abnormal growth of the mucous membrane lining the uterus resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.
- Endometrioid Carcinoma Incidence/prevalence Measurement [CMO:0001758] — Any measurement in which the number of individuals in a study population that display endometrioid carcinoma at a point in time or develop endometrioid carcinoma within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Endometrioid carcinoma is a malignant new growth occurring in the uterine fundus and ovaries and characterized by glandular patterns resembling those of the endometrium, which is made up of epithelial cells tending to infiltrate surrounding tissues and to give rise to metastases.
- Endometrium Ribonucleic Acid Level [CMO:0004003] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in the endometrium, the glandular mucous membrane lining of the uterine cavity that is hormonally responsive during the estrous/menstrual cycle and during pregnancy.
- Enterocolitis Severity Measurement [CMO:0002137] — Any measurement of the degree to which the presentation of the enterocolitis disease state, i.e. inflammation of the mucosa of both the small and large intestines, causes pain or damage, or interferes with the normal functioning of an organism or any part thereof.
- Enterocolitis Severity Score [CMO:0002138] — A measurement of enterocolitis severity which is derived from a combination of multiple measurements and/or an objective or subjective ranking or rating system according to a specified formula or set of criteria.
- Epidermis Ribonucleic Acid Level [CMO:0003932] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in epidermis, the outer epithelial layer of skin that is superficial to the dermis.
- Epididymal Fat Pad Morphological Measurement [CMO:0000657] — Measurement of the physical form or structure of the encapsulated adipose tissue surrounding the epididymis, the structure along the posterior body of the testis.
- Epididymal Fat Pad Weight [CMO:0000357] — Weight of the encapsulated adipose tissue surrounding the epididymis, the structure along the posterior body of the testis.
- Epididymal Fat Pad Weight to Body Weight Ratio [CMO:0000658] — A calculated measurement in which the weight of the epididymal fat pad is divided by the total weight of the body and the result presented as a ratio, fraction, quotient or percentage.
- Epididymal Fat Pad Weight to Tibia Length Ratio [CMO:0001201] — A calculated value in which the weight of the epididymal fat pad, the encapsulated adipose tissue that is attached to the epididymis, is divided by the length of the tibia, the inner and larger bone of the lower leg or hindlimb, and presented as a ratio, fraction, quotient or percentage, thus normalizing it to the length of the leg and, by extension, to the length of the body.
- Epididymal Plus Perirenal White Adipose Tissue Weight to Body Weight Ratio [CMO:0001195] — A calculated value in which the sum of the weights of the white adipose tissue associated with the epididymus and that surrounding the kidneys is divided by the total weight of the body and presented as a ratio, fraction, quotient or percent, thus normalizing it to body weight.
- Epididymides Weight [CMO:0000637] — The heaviness of the epididymides, i.e., the degree to which one or both of the epididymides is drawn toward the ground. The epididymis is an elongated cordlike structure along the posterior border of the testis; its coiled duct provides for storage, transit, and maturation of spermatozoa and is continuous with the ductus deferens.
- Epididymidis Wet Weight [CMO:0001602] — The heaviness, i.e. the degree to which an object is drawn toward the earth by gravity, of one or both of the epididymides, measured after removal from the body but without desiccation. The epididymis is an elongated cordlike structure along the posterior border of the testis; its coiled duct provides for storage, transit, and maturation of spermatozoa and is continuous with the ductus deferens.
- Epididymis Ribonucleic Acid Composition Measurement [CMO:0003332] —
- Epithelium of Bronchus Ribonucleic Acid Composition Measurement [CMO:0003351] —
- ERG Oscillatory Potential [CMO:0003703] — Oscillatory potentials (OPs) (four to six wavelets) can be seen on the ascending limb of most b-waves in both scotopic and photopic bright flash ERG recording. Oscillatory potentials are thought to reflect activity initiated by amacrine cells in the inner retina.
- Erythrocyte Sedimentation Rate [CMO:0003910] — This is the sinking velocity red corpuscles, i.e., the rapidity which which the red cells sink in a mass of drawn blood.
- Esophagus Ribonucleic Acid Composition Measurement [CMO:0003269] —
- Ethanol Drink Intake Rate [CMO:0001407] — The amount of ethanol, a colorless volatile flammable liquid CH3CH2OH that is the intoxicating agent in liquors, consumed per unit time.
- Ethanol Drink Intake Rate to Body Weight Ratio [CMO:0001616] — A calculated measurement in which the amount of ethanol, the colorless, volatile, flammable liquid, CH3CH2OH, produced by yeast fermentation of carbohydrates or synthesized by hydration of ethylene, consumed as a drink, that is, a liquid brought into the mouth and swallowed to quench thirst, for nourishment, etc., per unit time, is divided by the total weight of the body and the result presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and, by extension, to the size of the organism.
- Ethanol Drink Intake Volume [CMO:0001588] — Measurement of the size of the three dimensional space occupied by the amount of ethanol, the colorless, volatile, flammable liquid, CH3CH2OH, produced by yeast fermentation of carbohydrates or synthesized by hydration of ethylene, consumed in a specified period of time.
- Ethanol Intake Volume to Total Fluid Intake Volume Ratio [CMO:0001591] — A calculated measurement of ethanol intake in which the volume, that is, the size of the three dimensional space occupied by a solution of ethanol, a colorless, volatile, flammable liquid, CH3CH2OH, produced by yeast fermentation of carbohydrates or synthesized by hydration of ethylene, consumed in a specified period of time is divided by the total volume of all fluids consumed within that period, and presented as a ratio, fraction, quotient or percentage.
- Ethanol Intake Weight [CMO:0001763] — Measurement of the weight or heaviness of a solution of ethanol, the colorless, volatile, flammable liquid, CH3CH2OH, produced by yeast fermentation of carbohydrates or synthesized by hydration of ethylene, that is consumed as a drink, a liquid brought into the mouth and swallowed to quench thirst, for nourishment, etc., in a specified period of time.
- Ethanol Intake Weight to Body Weight Ratio [CMO:0001765] — A calculated measurement in which ethanol intake weight is divided by total weight of the body and presented as a ratio, fraction, quotient or percentage, thus normalizing it to body weight and, by extension, to the size of the organism. Ethanol intake weight is the heaviness of a solution of ethanol, the colorless, volatile, flammable liquid, CH3CH2OH, produced by yeast fermentation of carbohydrates or synthesized by hydration of ethylene, that is consumed as a drink, a liquid brought into the mouth and swallowed to quench thirst, for nourishment, etc., in a specified period of time. Body weight is the heaviness or degree to which a body is drawn toward the earth by gravity.
- Exocrine Gland Fluid/secretion Measurement [CMO:0000785] — Measurement involving a fluid or other secretion produced by an exocrine gland, that is, one which discharges its secretions through a duct opening on an internal or external surface of the body.
- Exocrine Gland Measurement [CMO:0000784] — Measurements involving an exocrine gland or its product(s). An exocrine gland is one which discharges its secretions through a duct opening on an internal or external surface of the body.
- Exocrine Pancreas Measurement [CMO:0001051] — Any measurement, morphological or physiological, involving the exocrine gland portion of the pancreas, that is, the elongated, racemose gland which secretes digestive enzymes into the intestine.
- Experimental Arthritis Incidence/prevalence Measurement [CMO:0001452] — Any measurement in which the number of individuals in a study population that display experimental arthritis at a point in time or develop experimental arthritis within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Experimental arthritis is a disease characterized by inflammation of one or more joints, the sites of junction or union between bones, especially those that allow motion of the bones, in which the condition is a result of the artificial induction of joint inflammation.
- Experimental Arthritis Onset/diagnosis Measurement [CMO:0001449] — Any measurement which expresses a quantity related to the beginning, early stages or development of experimental arthritis, or to the official determination of experimental arthritis as the cause of the observed symptom(s). Experimental arthritis is a disease characterized by inflammation of one or more joints, the sites of junction or union between bones, especially those that allow motion of the bones, in which the condition is a result of the artificial induction of joint inflammation.
- Experimental Arthritis Severity Measurement [CMO:0001459] — Any measurement of the degree to which the presentation of the experimental arthritis disease state, i.e. the state characterized by inflammation of one or more joints in which the condition is a result of the artificial induction of joint inflammation, causes pain or damage.
- Experimental Autoimmune Encephalomyelitis Duration [CMO:0001424] — Measurement of the length of time between onset of experimental autoimmune encephalomyelitis (EAE), an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells, and either the point at which the measurement is taken, the resolution of symptoms or the death of the organism.
- Experimental Autoimmune Encephalomyelitis Incidence/prevalence Measurement [CMO:0001046] — Any measurement in which the number of individuals in a study population that display experimental autoimmune encephalomyelitis (EAE) at a point in time or develop EAE within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. EAE is an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells.
- Experimental Autoimmune Encephalomyelitis Onset/diagnosis Measurement [CMO:0001404] — Any measurement which expresses a quantity related to the beginning, early stages or development of experimental autoimmune encephalomyelitis (EAE), or to the official determination of a disease as the cause of the observed symptom(s) of EAE. EAE is an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells.
- Experimental Autoimmune Encephalomyelitis Progression Measurement [CMO:0001423] — Any measurement related to the course of experimental autoimmune encephalomyelitis (EAE), an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells, for example, a series of stages or a succession of states in the disease process or the duration of the disease state.
- Experimental Autoimmune Encephalomyelitis Severity Measurement [CMO:0001418] — Any measurement of the degree to which the presentation of the experimental autoimmune encephalomyelitis disease state, i.e. the animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells, causes pain or damage.
- Experimental Autoimmune Encephalomyelitis Severity Score [CMO:0001419] — A rating, usually expressed numerically and based on the degree to which certain qualities or conditions are present, of the degree to which the presentation of the experimental autoimmune encephalomyelitis disease state, i.e. the animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells, causes pain or damage.
- Experimental Autoimmune Neuritis Incidence/prevalence Measurement [CMO:0001521] — Any measurement in which the number of individuals in a study population that display experimental autoimmune neuritis (EAN), inflammation of peripheral nerves caused by an anti-self immune reaction experimentally or artificially triggered by introduction of peripheral nerve tissue or protein components in adjuvant, at a point in time or develop EAN within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
- Experimental Autoimmune Neuritis Onset/diagnosis Measurement [CMO:0001524] — Any measurement which expresses a quantity related to the beginning, early stages or development of experimental autoimmune neuritis (EAN), inflammation of peripheral nerves caused by an anti-self immune reaction experimentally or artificially triggered by introduction of peripheral nerve tissue or protein components in adjuvant, or to the official determination of EAN as the cause of the observed symptom(s).
- Experimental Autoimmune Neuritis Severity Measurement [CMO:0001527] — Any measurement of the degree to which the presentation of the experimental autoimmune neuritis (EAN) disease state, i.e. inflammation of peripheral nerves caused by an anti-self immune reaction experimentally or artificially triggered by introduction of peripheral nerve tissue or protein components in adjuvant, causes pain or damage.
- Experimental Autoimmune Neuritis Severity Score [CMO:0001528] — A measurement of the degree to which the presentation of the experimental autoimmune neuritis (EAN) disease state, i.e. inflammation of peripheral nerves caused by an anti-self immune reaction experimentally or artificially triggered by introduction of peripheral nerve tissue or protein components in adjuvant, causes pain or damage when that value is derived from a combination of multiple measurements and/or objective or subjective severity scores according to a specified formula or set of criteria.
- Experimental Autoimmune Uveitis Score [CMO:0001504] — A measurement of experimental autoimmune uveitis (EAU) severity which is derived from a combination of multiple measurements and/or objective or subjective severity scores according to a specified formula or set of criteria. EAU is an inflammation of the uvea--the vascular, pigmentary, middle coat of the eye, comprising the choroid, ciliary body, and iris--resulting from experimental or artificial stimulation of an immune response by the body against its own tissue.
- Experimental Autoimmune Uveitis Severity Measurement [CMO:0001503] — Any measurement of the degree to which the presentation of inflammation of the uvea--the vascular, pigmentary, middle coat of the eye, comprising the choroid, ciliary body, and iris--resulting from experimental or artificial stimulation of an immune response by the body against its own tissue, causes pain or damage.
- Exploratory Movement Measurement [CMO:0003806] — A measurement of time, movement type, or location of a subject's exploration of an object, location, or other entity.
- Extensor Digitorum Longus Muscle Weight [CMO:0002965] — The weight or the measure of the heaviness of extensor digitorum longus muscle, which is a penniform muscle of the lateral front part of the hindlimb responsible for extension of the digits and dorsiflexion of the ankle.
- Extensor Digitorum Longus Muscle Weight to Body Weight Ratio [CMO:0002967] —
- Exudate Measurement [CMO:0001427] — Any measurement of fluid, cells, or other substances that have been slowly exuded, or discharged, from tissues, cells or blood vessels and deposited within tissues or on tissue surfaces.
- Eye Measurement [CMO:0003079] —
- Eye Morphological Measurement [CMO:0003080] — Measurement of the physical form or structure of the eye, the organ of vision, which is sensitive to light and in which the optic nerve terminates.
- Eye Physiological Measurement [CMO:0003652] — Any measurement related to the function of or processes involved in the ophthalmic perception of light.
- Eye Ribonucleic Acid Level [CMO:0003298] —
Data returned: 101 terms all with first letter "E".
Data updated: Sep 01, 2024